Therapeutic Group: Gastro Intestinal Disorders Presentation Lefoam Drops: Each ml drop contains Simethicone USP 67 mg. Description Simethicone is an effective antiflatulent. The clinical use of Simethicone is based on its antifoaming properties. The defoaming action of Simethicone relieves flatulence by dispersing and preventing the formation of mucus-surrounded gas pockets in the GI tract. It […]
Therapeutic Group: Herbal and Nutraceuticals Presentation Each capsule contains standardized extract of “Milk Thistle†seed equivalent to 140 mg Silymarin. Description Silymarin is Flavonolignan extracted from plant “Milk Thistleâ€. It consists of four flavonolignan isomers namely- silybin, isosilybin, silydianin and silychristin. Silymarin is well known hepatoprotective agent. The liver-protecting and liver-repairing functions are due to […]
Therapeutic Group: Herbal and Nutraceuticals Presentation Each capsule contains standardized extract of “Milk Thistle†seed equivalent to 70 mg Silymarin. Description Silymarin is Flavonolignan extracted from plant “Milk Thistleâ€. It consists of four flavonolignan isomers namely- silybin, isosilybin, silydianin and silychristin. Silymarin is well known hepatoprotective agent. The liver-protecting and liver-repairing functions are due to […]
Therapeutic Group: Others Presentation Silosin 4: Each capsule contains Silodosin INN 4 mg. Silosin 8: Each capsule contains Silodosin INN 8 mg. Description Silodosin, a selective antagonist of alpha-1adrenoreceptors. Silodosin is a white to pale yellowish white powder that melts at approximately 105 to 109 °C. It is very soluble in acetic acid, freely soluble […]
Therapeutic Group: Urological Presentation Silagra 50 tablet: Each tablet contains Sildenafil Citrate INN 70.24 mg equivalent to Sildenafil 50 mg. Silagra 100 tablet: Each tablet contains Sildenafil Citrate INN 140.48 mg equivalent to Sildenafil 100 mg. Description Sildenafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation […]
Therapeutic Group: Phosphate Binders Presentation Each tablet contains Sevelamer Hydrochloride INN 400 mg. Description Sevelamer Hydrochloride is a new treatment for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. Elevated serum phosphorus levels or uncontrolled hyperphosphatemia leads to development of secondary hyperparathyroidism, renal bone disease, calcification of vascular and […]
Therapeutic Group: Drugs of Nervous System Presentation Repose 25: Each tablet contains Sertraline Hydrochloride INN equivalent to Sertraline 25 mg. Repose 50: Each tablet contains Sertraline Hydrochloride INN equivalent to Sertraline 50 mg. Repose 100: Each tablet contains Sertraline Hydrochloride INN equivalent to Sertraline 100 mg. Description Sertraline has potent and selective inhibitory action on […]
Therapeutic Group: Anti Diabetic Presentation FitaroTM 0.25 mg injection: Each pre-filled syringe contains Semaglutide INN 0.25 mg in 0.5 ml solution for injection. FitaroTM 0.50 mg injection: Each pre-filled syringe contains Semaglutide INN 0.50 mg in 0.5 ml solution for injection. FitaroTM 1 mg injection: Each pre-filled syringe contains Semaglutide INN 1 mg in 0.5 […]
Therapeutic Group: GLP-1 receptor agonist Presentation OrsemaTM 0.25 mg Injection: Each pre-filled syringe contains Semaglutide INN 0.25 mg in 0.188 ml solution for injection. OrsemaTM 0.50 mg Injection: Each pre-filled syringe contains Semaglutide INN 0.50 mg in 0.375 ml solution for injection. Description Semaglutide is a GLP-1 analogue with 94% sequence as same as to […]
Therapeutic Group: Others Presentation Palopag 200: Each film coated tablet contains Selexipag INN 200 mcg. Palopag 400: Each film coated tablet contains Selexipag INN 400 mcg. Description Selexipag is a selective non-prostanoid IP prostacyclin receptor agonist. Selexipag is a pale yellow crystalline powder that is practically insoluble in water. In the solid state selexipag is […]